1.

Record Nr.

UNINA9910139970803321

Titolo

Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.]

Pubbl/distr/stampa

Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010

ISBN

1-282-38511-9

9786612385117

1-4443-1705-9

1-4443-1706-7

Edizione

[3rd ed.]

Descrizione fisica

1 online resource (576 p.)

Altri autori (Persone)

ClavienPierre-Alain

Abou-AlfaGhassan (MSKCC.)

CassilethBarrie R (MSKCC.)

DaiMenghua (MSKCC.)

FongYuman (MSKCC.)

GonzalezLorena (MSKCC.)

GubiliJyothirmai (MSKCC.)

KemenyNancy (MSKCC.)

Disciplina

616.99436

Soggetti

Liver - Cancer - Treatment

Oncology

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Malignant Liver Tumors: Current and Emerging Therapies, THIRD EDITION; Contents; Contributors; Preface; Acknowledgments; Abbreviations; Section 1: Introduction; Section 2: Epidemiology and Diagnosis; Section 3: Systemic and Regional Therapies; Section 4: Resection, Ablation or Transplantation for Liver Tumors; Section 5: Guidelines for Liver Tumor Treatment; Section 6: Emerging Therapies; Section 7: Special Tumors, Population, and Special Considerations; Index

Sommario/riassunto

This comprehensive and critical review of current and established



treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr. Clavien and his contributors consider all the options - radiological, surgical, pharmaceutical, and emerging/novel therapies - and help you find the best single or combined therapy. Building on the success of the previous edition, this extremely thorough revision:features a new section on Guidelines for Liver Tumors, wh